Ostrom QT, Cioffi G, Waite K, et al. (2021) CBTRUS Statistical Report: primary brain and other central nervous system tumors diagnosed in the United States in 2014–2018. Neuro Oncol 23: iii1-iii105. https://doi.org/10.1093/neuonc/noab200

Board WCoTE (2021) Central nervous system tumours. International Agency for Research on Cancer, Lyon

Tomita Y, Hibler EA, Suruga Y et al (2022) Age is a major determinant for poor prognosis in patients with pilocytic astrocytoma: a SEER population study. Clin Exp Med. https://doi.org/10.1007/s10238-022-00882-5

Article  PubMed  Google Scholar 

Dodgshun AJ, Maixner WJ, Hansford JR et al (2016) Low rates of recurrence and slow progression of pediatric pilocytic astrocytoma after gross-total resection: justification for reducing surveillance imaging. J Neurosurg Pediatr 17:569–572. https://doi.org/10.3171/2015.9.Peds15449

Article  PubMed  Google Scholar 

Jungk C, Reinhardt A, Warta R et al (2019) Extent of resection, MGMT promoter methylation status and tumor location independently predict progression-free survival in adult sporadic pilocytic astrocytoma. Cancers (Basel). https://doi.org/10.3390/cancers11081072

Article  Google Scholar 

Nelson AJ, Zakaria R, Jenkinson MD et al (2019) Extent of resection predicts risk of progression in adult pilocytic astrocytoma. Br J Neurosurg 33:343–347. https://doi.org/10.1080/02688697.2018.1549315

Article  PubMed  Google Scholar 

Mair MJ, Wöhrer A, Furtner J et al (2020) Clinical characteristics and prognostic factors of adult patients with pilocytic astrocytoma. J Neurooncol 148:187–198. https://doi.org/10.1007/s11060-020-03513-9

CAS  Article  PubMed  PubMed Central  Google Scholar 

Bond KM, Hughes JD, Porter AL et al (2018) Adult pilocytic astrocytoma: an institutional series and systematic literature review for extent of resection and recurrence. World Neurosurg 110:276–283. https://doi.org/10.1016/j.wneu.2017.11.102

Article  PubMed  Google Scholar 

Theeler BJ, Ellezam B, Sadighi ZS et al (2014) Adult pilocytic astrocytomas: clinical features and molecular analysis. Neuro Oncol 16:841–847. https://doi.org/10.1093/neuonc/not246

CAS  Article  PubMed  PubMed Central  Google Scholar 

Jones DT, Gronych J, Lichter P et al (2012) MAPK pathway activation in pilocytic astrocytoma. Cell Mol Life Sci 69:1799–1811. https://doi.org/10.1007/s00018-011-0898-9

CAS  Article  PubMed  Google Scholar 

Kurani H, Gurav M, Shetty O et al (2019) Pilocytic astrocytomas: BRAFV600E and BRAF fusion expression patterns in pediatric and adult age groups. Childs Nerv Syst 35:1525–1536. https://doi.org/10.1007/s00381-019-04282-1

Article  PubMed  Google Scholar 

Capper D, Jones DTW, Sill M et al (2018) DNA methylation-based classification of central nervous system tumours. Nature 555:469–474. https://doi.org/10.1038/nature26000

CAS  Article  PubMed  PubMed Central  Google Scholar 

Kameda M, Otani Y, Ichikawa T et al (2017) Congenital glioblastoma with distinct clinical and molecular characteristics: case reports and a literature review. World Neurosurg. https://doi.org/10.1016/j.wneu.2017.02.026

Article  PubMed  Google Scholar 

Reinhardt A, Stichel D, Schrimpf D et al (2018) Anaplastic astrocytoma with piloid features, a novel molecular class of IDH wildtype glioma with recurrent MAPK pathway, CDKN2A/B and ATRX alterations. Acta Neuropathol 136:273–291. https://doi.org/10.1007/s00401-018-1837-8

CAS  Article  PubMed  Google Scholar 

Johnson DR, Brown PD, Galanis E et al (2012) Pilocytic astrocytoma survival in adults: analysis of the Surveillance, Epidemiology, and End Results Program of the National Cancer Institute. J Neurooncol 108:187–193. https://doi.org/10.1007/s11060-012-0829-0

Article  PubMed  Google Scholar 

Stuer C, Vilz B, Majores M et al (2007) Frequent recurrence and progression in pilocytic astrocytoma in adults. Cancer 110:2799–2808. https://doi.org/10.1002/cncr.23148

Article  PubMed  Google Scholar 

Voronina N, Aichmuller C, Kolb T et al (2021) The age of adult pilocytic astrocytoma cells. Oncogene 40:2830–2841. https://doi.org/10.1038/s41388-021-01738-0

CAS  Article  PubMed  PubMed Central  Google Scholar 

Rodriguez FJ, Scheithauer BW, Burger PC et al (2010) Anaplasia in pilocytic astrocytoma predicts aggressive behavior. Am J Surg Pathol 34:147–160. https://doi.org/10.1097/PAS.0b013e3181c75238

Article  PubMed  Google Scholar 

Louis DN, Perry A, Reifenberger G et al (2016) The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathol 131:803–820. https://doi.org/10.1007/s00401-016-1545-1

Article  PubMed  Google Scholar 

Bender K, Perez E, Chirica M et al (2021) High-grade astrocytoma with piloid features (HGAP): the Charite experience with a new central nervous system tumor entity. J Neurooncol 153:109–120. https://doi.org/10.1007/s11060-021-03749-z

Article  PubMed  PubMed Central  Google Scholar 

Giannini C, Scheithauer BW, Burger PC et al (1999) Cellular proliferation in pilocytic and diffuse astrocytomas. J Neuropathol Exp Neurol 58:46–53. https://doi.org/10.1097/00005072-199901000-00006

CAS  Article  PubMed  Google Scholar 

Collins VP, Jones DT, Giannini C (2015) Pilocytic astrocytoma: pathology, molecular mechanisms and markers. Acta Neuropathol 129:775–788. https://doi.org/10.1007/s00401-015-1410-7

CAS  Article  PubMed  PubMed Central  Google Scholar 

Ono T, Takahashi M, Hatakeyama J et al (2019) Clinical significance of molecular diagnosis of pilocytic astrocytoma: a case report. NMC Case Rep J 6:95–99. https://doi.org/10.2176/nmccrj.cr.2018-0282

Article  PubMed  PubMed Central  Google Scholar 

Shibui S, Narita Y, Mizusawa J et al (2013) Randomized trial of chemoradiotherapy and adjuvant chemotherapy with nimustine (ACNU) versus nimustine plus procarbazine for newly diagnosed anaplastic astrocytoma and glioblastoma (JCOG0305). Cancer Chemother Pharmacol 71:511–521. https://doi.org/10.1007/s00280-012-2041-5

CAS  Article  PubMed  Google Scholar